Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 08, 2023

SELL
$32.09 - $37.51 $4.76 Million - $5.56 Million
-148,229 Reduced 95.78%
6,532 $216,000
Q2 2023

Aug 21, 2023

SELL
$36.12 - $41.79 $4.47 Million - $5.17 Million
-123,696 Reduced 44.42%
154,761 $5.68 Million
Q1 2023

May 17, 2023

BUY
$39.39 - $51.28 $5.55 Million - $7.22 Million
140,826 Added 102.32%
278,457 $11.4 Million
Q4 2022

Feb 15, 2023

BUY
$41.75 - $54.5 $5.75 Million - $7.5 Million
137,631 New
137,631 $7.05 Million
Q2 2020

Aug 10, 2020

SELL
$30.12 - $36.54 $449,300 - $545,067
-14,917 Closed
0 $0
Q1 2020

May 22, 2020

SELL
$27.03 - $38.62 $5.07 Million - $7.25 Million
-187,723 Reduced 92.64%
14,917 $486,000
Q4 2019

Feb 20, 2020

SELL
$32.92 - $37.36 $1.09 Million - $1.23 Million
-32,973 Reduced 13.99%
202,640 $7.94 Million
Q3 2019

Nov 19, 2019

BUY
$32.49 - $42.13 $133,793 - $173,491
4,118 Added 1.78%
235,613 $8.47 Million
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $27,624 - $31,015
747 Added 0.32%
231,495 $10 Million
Q1 2019

May 02, 2019

BUY
$37.5 - $41.2 $8.4 Million - $9.23 Million
223,982 Added 3310.4%
230,748 $9.8 Million
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $260,288 - $296,756
6,766 New
6,766 $295,000
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $191,268 - $221,897
-5,994 Closed
0 $0
Q4 2017

Feb 22, 2018

BUY
$33.26 - $35.29 $5,487 - $5,822
165 Added 2.83%
5,994 $217,000
Q3 2017

Nov 02, 2017

BUY
$31.0 - $34.15 $180,699 - $199,060
5,829
5,829 $208,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Ccm Investment Advisers LLC Portfolio

Follow Ccm Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.